NNBP — Nanobac Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $4.12m
- $0.02m
Annual cashflow statement for Nanobac Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB/A | 10KSB/A | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.7 | -8.52 | -3.69 | -4.97 | -6.58 |
| Depreciation | |||||
| Non-Cash Items | 0.784 | 3.44 | 0.798 | 1.51 | 3.45 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.578 | 0.961 | -0.236 | 0.341 | 1.75 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.16 | -3.4 | -2.37 | -2.58 | -0.911 |
| Capital Expenditures | -0.018 | -0.038 | -0.041 | -0.013 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.216 | 0.202 | 0 | -0.003 | 0.05 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.198 | 0.164 | -0.041 | -0.016 | 0.048 |
| Financing Cash Flow Items | 2 | 2.07 | 2.14 | 2.74 | 0.893 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.02 | 3.22 | 2.33 | 2.69 | 0.911 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.05 | -0.032 | -0.009 | 0.031 | -0.036 |